Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2014 Nov 25;3(2):236–242. doi: 10.1016/j.jaip.2014.09.022

Table V.

Global Assessment of Patients with SAD Receiving Immunoglobulin Replacement

Age Pertinent Past Medical History Global Assessment by Treating Physician
55

  • Allergic rhinitis

  • Asthma (mild†)

 Improved greatly with fewer sinus infections.
37

  • Non-allergic rhinitis (negative skin test)

  • Asthma (moderate; normal FEV1)

  • FESS δ

 Improved greatly. Reduced frequency of sinus infections and asthma exacerbations. Less prednisone and fewer acute physician visits.
64

  • Allergic rhinitis -

  • Asthma (moderate)

 Improved greatly. Reduced severity and frequency of sinus infections.
49

  • Asthma (mild)

  • Non-allergic rhinitis

  • FESS

  • Pneumonia

  • Recurrent respiratory infections (bronchitis)

 Improved greatly. Reduced severity and frequency of sinus infections.
66

  • Pneumonia

  • Neuropathy

 Improved greatly: Reduced severity and frequency of sinus infections. Fewer antibiotics courses.
43

  • Allergic rhinitis

  • Asthma (moderate)

  • FESS

 Improved but continues to have sinus infections about three times a year requiring treatment with antibiotics.
59

  • Allergic rhinitis

  • Asthma (moderate)

 Improved greatly.
37

  • Asthma (severe)

  • Pneumonia

  • FESS

 Improved but continues to have sinus infections.
52

  • Allergic rhinitis

  • Asthma (mild)

  • Pneumonia (recurrent)

 Improved but sinus disease remains hard to manage; however fewer antibiotics courses.
67

  • Asthma (severe)

  • Nasal polyposis

  • FESS

 Improved greatly with fewer sinus infections.
†

Asthma severity was graded according to the National Heart, Lung, and Blood Institute’s 2007 NAEPP Expert Panel Report 3 guidelines using %FEV1 values19

δ

Functional endoscopic sinus surgery.